Search Results

Filter
  • 1-10 of  17,501 results for ""HEPATITIS B""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis.

  • Authors : Cao QH; Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China.; Liu H

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/blood ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/virology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/etiology

  • Source: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2024 Aug; Vol. 39 (8), pp. 1464-1475. Date of Electronic Publication: 2024 Apr 30.Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Estimating the key outcomes and hepatocellular carcinoma risk in patients in immune-tolerant phase of chronic hepatitis B virus infection: A systematic review and meta-analysis.

  • Authors : Liu M; Department of Infectious Disease and Hepatic Disease, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.; Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/epidemiology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/virology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology

  • Source: Reviews in medical virology [Rev Med Virol] 2024 Jul; Vol. 34 (4), pp. e2570.Publisher: Wiley Country of Publication: England NLM ID: 9112448 Publication Model: Print Cited Medium: Internet ISSN: 1099-1654 (Electronic)

Record details

×
Academic Journal

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2.

  • Authors : Agarwal K; Institute of Liver Studies, King's College Hospital, London, England. Electronic address: .; Buti M

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/virology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use

  • Source: Journal of hepatology [J Hepatol] 2024 Sep; Vol. 81 (3), pp. 404-414. Date of Electronic Publication: 2024 Apr 05.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B.

  • Authors : Feng Z; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.; Fu J

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/metabolism

  • Source: Hepatology international [Hepatol Int] 2024 Aug; Vol. 18 (4), pp. 1122-1134. Date of Electronic Publication: 2024 Jun 03.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Hepatitis B Virus Infection in Eastern Libya: Current Efforts for Overcoming Regional Barriers for Its Elimination.

  • Authors : Ismail F; Department of Clinical Laboratory, Faculty of Medical Technology, University of Tobruk, Tobruk, Libya. .; Blood Transmitted Diseases Department, National Centre for Disease Control, Tobruk, Libya. .

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/epidemiology ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/prevention & control ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/therapy

  • Source: Journal of community health [J Community Health] 2024 Aug; Vol. 49 (4), pp. 693-699. Date of Electronic Publication: 2024 Feb 23.Publisher: Springer Country of Publication: Netherlands NLM ID: 7600747 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta-analysis.

  • Authors : Rui F; Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.; Department of Infectious Disease, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Hepatitis B e Antigens*/Hepatitis B e Antigens*/Hepatitis B e Antigens*/blood

  • Source: Journal of viral hepatitis [J Viral Hepat] 2024 Jul; Vol. 31 (7), pp. 372-382. Date of Electronic Publication: 2024 Apr 08.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Investigating the role of GTPase in inhibiting HBV replication and enhancing interferon therapy efficacy in chronic hepatitis B patients.

  • Authors : Quan D; Hepatobiliary Surgery, The Sixth People's Hospital of Shenyang, Shenyang, China.; Wang P

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/virology ; Hepatitis B virus*/Hepatitis B virus*/Hepatitis B virus*/drug effects

  • Source: Microbial pathogenesis [Microb Pathog] 2024 Sep; Vol. 194, pp. 106821. Date of Electronic Publication: 2024 Jul 30.Publisher: Academic Press Country of Publication: England NLM ID: 8606191 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.

  • Authors : Zeng QL; Department of Infectious Diseases and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. .; Chen RY

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Aug 15; Vol. 24 (1), pp. 830. Date of Electronic Publication: 2024 Aug 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
Academic Journal

A high functional cure rate was induced by pegylated interferon alpha-2b treatment in postpartum hepatitis B e antigen-negative women with chronic hepatitis B virus infection: an exploratory study.

  • Authors : Zhong W; Department of Infectious Disease, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Yan L

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Polyethylene Glycols*/Polyethylene Glycols*/Polyethylene Glycols*/therapeutic use ; Recombinant Proteins*/Recombinant Proteins*/Recombinant Proteins*/therapeutic use

  • Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Aug 08; Vol. 14, pp. 1426960. Date of Electronic Publication: 2024 Aug 08 (Print Publication:Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B.

  • Authors : Johannessen A; Department of Infectious Diseases, Vestfold Hospital Trust, Tønsberg, Norway.; Department of Infectious Diseases, Regional Advisory Unit for Imported and Tropical Diseases, Oslo University Hospital, Oslo, Norway.

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Hepatitis B e Antigens*/Hepatitis B e Antigens*/Hepatitis B e Antigens*/blood

  • Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Aug; Vol. 60 (4), pp. 434-445. Date of Electronic Publication: 2024 Jul 05.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  17,501 results for ""HEPATITIS B""